Literature DB >> 15849280

Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.

L Socas1, M Zumbado, O Pérez-Luzardo, A Ramos, C Pérez, J R Hernández, L D Boada.   

Abstract

Anabolic androgenic steroids (AAS) are used illicitly at high doses by bodybuilders. The misuse of these drugs is associated with serious adverse effects to the liver, including cellular adenomas and adenocarcinomas. We report two very different cases of adult male bodybuilders who developed hepatocellular adenomas following AAS abuse. The first patient was asymptomatic but had two large liver lesions which were detected by ultrasound studies after routine medical examination. The second patient was admitted to our hospital with acute renal failure and ultrasound (US) studies showed mild hepatomegaly with several very close hyperecogenic nodules in liver, concordant with adenomas at first diagnosis. In both cases the patients have evolved favourably and the tumours have shown a tendency to regress after the withdrawal of AAS. The cases presented here are rare but may well be suggestive of the natural course of AAS induced hepatocellular adenomas. In conclusion, sportsmen taking AAS should be considered as a group at risk of developing hepatic sex hormone related tumours. Consequently, they should be carefully and periodically monitored with US studies. In any case, despite the size of the tumours detected in these two cases, the possibility of spontaneous tumour regression must also be taken in account.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849280      PMCID: PMC1725213          DOI: 10.1136/bjsm.2004.013599

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  48 in total

1.  Hepatocellular adenoma associated with long-term exposure to phenobarbital: a paediatric case report.

Authors:  Caterina Cerminara; Valentina Bagnolo; Francesco De Leonardis; Antonella Coniglio; Denis Roberto; Eliana Compagnone; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2011-11-29       Impact factor: 1.475

Review 2.  Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.

Authors:  Eberhard Nieschlag; Elena Vorona
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

3.  Near-fatal spontaneous hepatic rupture associated with anabolic androgenic steroid use: a case report.

Authors:  J J Patil; B O'Donohoe; C F Loyden; D Shanahan
Journal:  Br J Sports Med       Date:  2007-01-15       Impact factor: 13.800

Review 4.  Severe cholestasis and renal failure associated with the use of the designer steroid Superdrol (methasteron): a case report and literature review.

Authors:  John Nasr; Jawad Ahmad
Journal:  Dig Dis Sci       Date:  2008-08-22       Impact factor: 3.199

Review 5.  Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Drug Alcohol Depend       Date:  2008-07-02       Impact factor: 4.492

Review 6.  Hepatocellular adenoma management: advances but still a long way to go.

Authors:  Jean Frédéric Blanc; Nora Frulio; Laurence Chiche; Paulette Bioulac-Sage; Charles Balabaud
Journal:  Hepat Oncol       Date:  2015-05-15

7.  Leydig cell tumor in an anabolic steroid abuser.

Authors:  S Belli; A Guidi; M Simoni; C Carani; A R Granata
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

8.  Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion.

Authors:  Junping Ao; Jiao Meng; Lei Zhu; Huizhen Nie; Chenchen Yang; Jinjun Li; Jianren Gu; Qiushi Lin; Weiwen Long; Xiaoqun Dong; Chao Li
Journal:  Mol Oncol       Date:  2012-07-05       Impact factor: 6.603

Review 9.  Liver masses: a clinical, radiologic, and pathologic perspective.

Authors:  Sudhakar K Venkatesh; Vishal Chandan; Lewis R Roberts
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-18       Impact factor: 11.382

Review 10.  Illicit anabolic-androgenic steroid use.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Horm Behav       Date:  2009-09-18       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.